Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,362 public trials 239 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Recruiting

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

NCT04988555

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +25 more
Locations
  • Hoag Family Cancer Center Newport Beach, California, United States
  • Stanford University Palo Alto, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Georgetown Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
View all 104 locations
View Trial Details
Recruiting

Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS

NCT05636514

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Prince of Wales Hospital Sydney, New South Wales, Australia
  • Royal Prince Alfred Hospital Sydney, New South Wales, Australia
  • Concord Repatriation and General Hospital Sydney, New South Wales, Australia
  • Nepean Hospital Sydney, New South Wales, Australia
View Trial Details
Recruiting

Venetoclax Basket Trial for High Risk Hematologic Malignancies

NCT05292664

Conditions
Acute Leukemia of Ambiguous Lineage, Acute Leukemia of Ambiguous Lineage in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, +28 more
Locations
  • University of California San Francisco-Benioff Children's Hospital San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta at Arthur M. Blank Hospital Atlanta, Georgia, United States
  • Ann & Robert H Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View Trial Details
Recruiting

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

NCT03970096

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +19 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions